Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment

<p>Abstract</p> <p>Background</p> <p>Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma. The expression of OPN in allergic rhinitis...

Full description

Bibliographic Details
Main Authors: O'Neil Serena E, Malmhäll Carina, Samitas Konstantinos, Pullerits Teet, Bossios Apostolos, Lötvall Jan
Format: Article
Language:English
Published: BMC 2010-11-01
Series:Allergy, Asthma & Clinical Immunology
Online Access:http://www.aacijournal.com/content/6/1/28
id doaj-35205e7ab1fa4616844a5e00d7557dfb
record_format Article
spelling doaj-35205e7ab1fa4616844a5e00d7557dfb2020-11-24T20:47:26ZengBMCAllergy, Asthma & Clinical Immunology1710-14841710-14922010-11-01612810.1186/1710-1492-6-28Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatmentO'Neil Serena EMalmhäll CarinaSamitas KonstantinosPullerits TeetBossios ApostolosLötvall Jan<p>Abstract</p> <p>Background</p> <p>Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma. The expression of OPN in allergic rhinitis (AR) is currently unknown, as is the effect of intranasal glucocorticosteroids (GCs) on that expression.</p> <p>Methods</p> <p>Subjects with AR were randomised to receive treatment with fluticasone propionate (FP) (n = 12) or a placebo (n = 16) over the grass pollen season and nasal biopsies were taken prior to, and during the season. OPN expression in the nasal mucosa was examined with immunohistochemistry. Healthy non-AR controls (n = 5) were used as a comparator.</p> <p>Results</p> <p>OPN expression was detected in epithelial cells, subepithelial infiltrating/inflammatory cells and cells lining the vessels and glands of all subjects. Comparison of the pre- and peak-pollen season biopsy sections in placebo treated patients revealed no increase in OPN expression during the grass pollen season (5.7% vs 6.4%). Treatment with a local glucocorticosteroid did not alter the expression of OPN during pollen exposure (6.2% vs 6.7%).</p> <p>Conclusion</p> <p>OPN has been increasingly associated with the pathogenesis of various Th2-mediated diseases. However, our finding that the OPN expression in the nasal mucosa of AR patients is not significantly affected by allergen exposure and is comparable to that of the healthy controls, suggests that intracellular OPN is not directly involved in the pathogenesis of allergic rhinitis.</p> http://www.aacijournal.com/content/6/1/28
collection DOAJ
language English
format Article
sources DOAJ
author O'Neil Serena E
Malmhäll Carina
Samitas Konstantinos
Pullerits Teet
Bossios Apostolos
Lötvall Jan
spellingShingle O'Neil Serena E
Malmhäll Carina
Samitas Konstantinos
Pullerits Teet
Bossios Apostolos
Lötvall Jan
Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment
Allergy, Asthma & Clinical Immunology
author_facet O'Neil Serena E
Malmhäll Carina
Samitas Konstantinos
Pullerits Teet
Bossios Apostolos
Lötvall Jan
author_sort O'Neil Serena E
title Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment
title_short Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment
title_full Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment
title_fullStr Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment
title_full_unstemmed Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment
title_sort quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment
publisher BMC
series Allergy, Asthma & Clinical Immunology
issn 1710-1484
1710-1492
publishDate 2010-11-01
description <p>Abstract</p> <p>Background</p> <p>Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma. The expression of OPN in allergic rhinitis (AR) is currently unknown, as is the effect of intranasal glucocorticosteroids (GCs) on that expression.</p> <p>Methods</p> <p>Subjects with AR were randomised to receive treatment with fluticasone propionate (FP) (n = 12) or a placebo (n = 16) over the grass pollen season and nasal biopsies were taken prior to, and during the season. OPN expression in the nasal mucosa was examined with immunohistochemistry. Healthy non-AR controls (n = 5) were used as a comparator.</p> <p>Results</p> <p>OPN expression was detected in epithelial cells, subepithelial infiltrating/inflammatory cells and cells lining the vessels and glands of all subjects. Comparison of the pre- and peak-pollen season biopsy sections in placebo treated patients revealed no increase in OPN expression during the grass pollen season (5.7% vs 6.4%). Treatment with a local glucocorticosteroid did not alter the expression of OPN during pollen exposure (6.2% vs 6.7%).</p> <p>Conclusion</p> <p>OPN has been increasingly associated with the pathogenesis of various Th2-mediated diseases. However, our finding that the OPN expression in the nasal mucosa of AR patients is not significantly affected by allergen exposure and is comparable to that of the healthy controls, suggests that intracellular OPN is not directly involved in the pathogenesis of allergic rhinitis.</p>
url http://www.aacijournal.com/content/6/1/28
work_keys_str_mv AT oneilserenae quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment
AT malmhallcarina quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment
AT samitaskonstantinos quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment
AT pulleritsteet quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment
AT bossiosapostolos quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment
AT lotvalljan quantitativeexpressionofosteopontininnasalmucosaofpatientswithallergicrhinitiseffectsofpollenexposureandnasalglucocorticoidtreatment
_version_ 1716810063800172544